BillionToOne, Inc. Class A Common Stock vs. Exagen Inc. Common Stock
BLLN
BillionToOne, Inc. Class A Common Stock
$105.92 -4.29%
VS XGNExagen Inc. Common Stock
$8.41 +6.86%
BillionToOne, Inc. Class A Common Stock (BLLN) comes out ahead, leading on 6 of 8 compared factors.
Size & Scale
| BLLN | XGN | |
|---|---|---|
| Market Cap | $5.00 billion | $203.74 million |
| Revenue (TTM) | $397.41 million | $71.12 million |
| Net Income (TTM) | $37.71 million | $-18,923,000 |
BLLN leads on 3 of 3 size & scale factors.
Valuation
| BLLN | XGN | |
|---|---|---|
| P/E Ratio | 102.83 | — |
| Price / Book | 9.31 | 16.68 |
| Price / Sales | 12.58 | 2.86 |
BLLN and XGN split the valuation factors evenly.
Profitability
| BLLN | XGN | |
|---|---|---|
| Net Margin | 9.49% | -26.61% |
| Return on Equity | 7.03% | -154.90% |
BLLN leads on 2 of 2 profitability factors.
Risk & Sentiment
| BLLN | XGN | |
|---|---|---|
| Short Interest | 0.12% | 0.02% |
XGN leads on 1 of 1 risk & sentiment factors.
Dig deeper: BLLN overview, BLLN financials, XGN overview, XGN financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.